Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Clinical Chemistry and Laboratory Medicine|June 19, 2012
Lack of consistency between two commercial ELISAs and against an in-house ELISA for the detection of CD36 in human plasmaSimon Lykkeboe, Anne Lone Larsen, Aase HandbergClinical Chemistry and Laboratory Medicine|October 15, 2017
Indirect method for validating transference of reference intervalsSimon Lykkeboe, Claus Gyrup Nielsen, Peter Astrup ChristensenClinical Chemistry and Laboratory Medicine|December 2, 2021
Blood sampling frequency as a proxy for comorbidity indices when identifying patient samples for review of reference intervalsSimon Lykkeboe, Stine Linding Andersen, Claus Gyrup Nielsen, et al.Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 2020
Effects of a whey protein pre-meal on bone turnover in participants with and without type 2 diabetes-A post hoc analysis of a randomised, controlled, crossover trialAnn Bjørnshave, Simon Lykkeboe, Bolette Hartmann, et al.Scandinavian Journal of Gastroenterology|July 30, 2020
Use of genetic testing for hypolactasia trait in the North Denmark RegionMorten Mørk, Stine Linding Andersen, Inge Søkilde Pedersen, et al.Frontiers in Endocrinology|April 1, 2021
Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With DiabetesJakob Kau Starup-Linde, Rikke Viggers, Bente Langdahl, et al.Bone|November 12, 2015
Differences in biochemical bone markers by diabetes type and the impact of glucoseJakob Starup-Linde, Simon Lykkeboe, Søren Gregersen, et al.The Journal of Clinical Endocrinology and Metabolism|January 13, 2016
Bone Structure and Predictors of Fracture in Type 1 and Type 2 DiabetesJakob Starup-Linde, Simon Lykkeboe, Søren Gregersen, et al.The Lancet. Diabetes & Endocrinology|April 26, 2020
Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trialJulius Simoni Leere, Jesper Karmisholt, Maciej Robaczyk, et al.The American Journal of Clinical Nutrition|August 4, 2017
Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trialMax Norman Tandrup Lambert, Catrine Bundgaard Thybo, Simon Lykkeboe, et al.Pageof 2